Josh Hartman

Josh Hartman is the Senior Director of Clinical Feasibility & Analytics at TriNetX, LLC, where they have played a key role since 2022. Previously, they were instrumental as a Clinical Analyst and Senior Clinical Analyst at TriNetX, contributing to the development of clinical trial protocols and training clients on the platform. Before joining TriNetX, Josh worked at Integrated DNA Technologies as a Production Scientist, synthesizing DNA and RNA oligonucleotides, and at Boston Medical Center as a Data Quality Specialist, leading data analytics for a large-scale hepatitis C screening program. They hold a degree from Boston University, obtained in 2016.